- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Belgian Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
8
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
8 companies
argenx
Market Cap: €28.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€471.10
7D
-6.3%
1Y
26.7%
UCB
Market Cap: €29.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€157.50
7D
-3.6%
1Y
13.2%
BioSenic
Market Cap: €1.9m
A biotech company, focuses on developing clinical assets.
BIOS
€0.0029
7D
38.1%
1Y
-84.7%
Financière de Tubize
Market Cap: €5.6b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€125.40
7D
-3.7%
1Y
19.2%
Oxurion
Market Cap: €305.9k
A biopharmaceutical company, develops medicines to prevent blindness in Belgium.
OXUR
€0.036
7D
-13.9%
1Y
-96.4%
Hyloris Pharmaceuticals
Market Cap: €164.1m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.86
7D
1.0%
1Y
-49.9%
European Medical Solutions
Market Cap: €19.9m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
ALEMS
€4.70
7D
0%
1Y
-41.4%
Celyad Oncology
Market Cap: €17.0m
A biotechnology company, focuses on research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.
CYAD
€0.41
7D
3.5%
1Y
33.1%